Management of Opioid Dependency During Pregnancy
Course #93093 - $15 -
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
The rate of infants being born with opioid dependence has been increasing over the past decade, with most sources linking this with the rising abuse of prescription opioids such as hydrocodone. As clinicians are more likely to encounter patients with an opioid abuse disorder who are or may become pregnant, it is vital that they have a clear understanding of the role of opioid-maintenance therapy as well as the effects of opioids on the fetus and the mother. The treatment plan should continue after the birth to ensure the child is cared for adequately and the parent receives the best care possible.
- INTRODUCTION
- BIOLOGIC EFFECTS OF OPIOIDS
- PREGNANCY IN PATIENTS USING OPIOIDS
- MEDICATIONS FOR OPIOID USE DISORDER (MOUD) DURING PREGNANCY
- NEWBORN ASSESSMENT FOR NEONATAL OPIOID WITHDRAWAL SYNDROME (NOWS)
- DISCHARGE PLANNING FOR PATIENTS WITH OUD/NOWS
- CONCLUSION
- Works Cited
- Evidence-Based Practice Recommendations Citations
This course is designed for substance abuse counselors, social workers, pharmacists, nurses, and any professional that assists women who are pregnant and misuse opioids. The material will also be useful for pediatric nurses working in the neonatal intensive care unit (NICU) and primary care providers in women's health care.
The purpose of this course is to provide healthcare professionals with the information necessary to appropriately care for pregnant women with opioid use disorder who are or are planning to become pregnant in order to minimize the adverse effects on the mother and fetus.
Upon completion of this course, you should be able to:
- Identify the biologic effects of opioid use and misuse on women.
- Describe the impact of opioid use on pregnancy and the importance of early recognition and prenatal care.
- Outline preferred medications for opioid use disorder (MOUD) in patients who are pregnant.
- Discuss the impact of opioid exposure in utero on fetal development and neonatal health.
- Evaluate the important aspects of discharge planning for infants treated for neonatal abstinence syndrome.
Davina Moss, PhD, CRC, CASAC, NCC, is the founder and President of Positive Direction and Associates, Inc., a consulting company that also provides educational seminars for medical professionals in the community. Dr. Moss is a Certified Rehabilitation Counselor, a National Certified Counselor, and a Credentialed Alcohol and Substance Abuse Counselor and has been a substance abuse counselor for more than 30 years. Dr. Moss received her Master’s degree in Deafness Rehabilitation from New York University in 1998 and Doctorate degree in Counselor Education with honors in 2005 from the State University of New York at Buffalo. Her dissertation Unresolved Grief and Loss Issues Related to Substance Abuse was published as a book titled Unresolved Grief and Loss Issues Related to Heroin Recovery in 2009. In 2017, her book The Positive Direction Model Opioid Use and Pregnancy was published.
Dr. Moss’ research interests are opioid use, the medical-patient relationship, and neonatal abstinence syndrome. She has written articles and continuing education courses and has also been a contributing author in three academic textbooks. Dr. Moss is an adjunct professor at New York University’s Applied Psychology Department and a Volunteer Research Assistant Professor at The State University of NY at Buffalo, Jacob’s School of Medicine.
Contributing faculty, Davina Moss, PhD, CRC, CASAC, NCC, has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
Mary Franks, MSN, APRN, FNP-C
Alice Yick Flanagan, PhD, MSW
Randall L. Allen, PharmD
The division planners have disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
Sarah Campbell
The Director of Development and Academic Affairs has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
The purpose of NetCE is to provide challenging curricula to assist healthcare professionals to raise their levels of expertise while fulfilling their continuing education requirements, thereby improving the quality of healthcare.
Our contributing faculty members have taken care to ensure that the information and recommendations are accurate and compatible with the standards generally accepted at the time of publication. The publisher disclaims any liability, loss or damage incurred as a consequence, directly or indirectly, of the use and application of any of the contents. Participants are cautioned about the potential risk of using limited knowledge when integrating new techniques into practice.
It is the policy of NetCE not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Supported browsers for Windows include Microsoft Internet Explorer 9.0 and up, Mozilla Firefox 3.0 and up, Opera 9.0 and up, and Google Chrome. Supported browsers for Macintosh include Safari, Mozilla Firefox 3.0 and up, Opera 9.0 and up, and Google Chrome. Other operating systems and browsers that include complete implementations of ECMAScript edition 3 and CSS 2.0 may work, but are not supported. Supported browsers must utilize the TLS encryption protocol v1.1 or v1.2 in order to connect to pages that require a secured HTTPS connection. TLS v1.0 is not supported.
The role of implicit biases on healthcare outcomes has become a concern, as there is some evidence that implicit biases contribute to health disparities, professionals' attitudes toward and interactions with patients, quality of care, diagnoses, and treatment decisions. This may produce differences in help-seeking, diagnoses, and ultimately treatments and interventions. Implicit biases may also unwittingly produce professional behaviors, attitudes, and interactions that reduce patients' trust and comfort with their provider, leading to earlier termination of visits and/or reduced adherence and follow-up. Disadvantaged groups are marginalized in the healthcare system and vulnerable on multiple levels; health professionals' implicit biases can further exacerbate these existing disadvantages.
Interventions or strategies designed to reduce implicit bias may be categorized as change-based or control-based. Change-based interventions focus on reducing or changing cognitive associations underlying implicit biases. These interventions might include challenging stereotypes. Conversely, control-based interventions involve reducing the effects of the implicit bias on the individual's behaviors. These strategies include increasing awareness of biased thoughts and responses. The two types of interventions are not mutually exclusive and may be used synergistically.